Vol
8. Issue 1 / January 14, 2008 |
|||||||
EtceteraRenowned Immunologist Richard Ulevitch Retires as Department Chair Ulevitch, who joined the institute in 1972, will continue to maintain a laboratory at Scripps Research as professor and chair emeritus while joining 5AM Ventures of Menlo Park, California, a venture capital company that makes seed and early-stage investments in next-generation life science companies. "It's with both regret and pleasure that I announce our friend and colleague's retirement as chair of the Department of Immunology," said Scripps Research President Richard A. Lerner. "The regret comes from the realization that Richard will no longer be providing his wise guidance to the department he has helped to build into one of the most productive within the institute, duly recognized for its significant research in the field of immunology worldwide. The pleasure comes from knowing that he will continue to contribute further important research to our understanding of the innate immune system, both at the Institute and in his new role in the private sector." "During the past three decades at the institute, it has been a privilege to work with each and every one of the faculty as a colleague and as chair of the Department of Immunology," Ulevitch said. "In total, my years at Scripps Research represent one of the greatest experiences of my professional life. I will surely miss the opportunities and relationships it has provided." Lerner said an international search will be conducted to find a new chair of the Immunology Department. In the interim, Professor Argyrios Theofilopoulos will serve as acting chair.
Tully is working on developing new methods to elucidate the biosynthetic pathway of endocannabinoids, small, lipid molecules important in the regulation of appetite and analgesia. Through manipulation of this pathway, it may be possible to relieve pain, promote hunger and inhibit nausea associated with radio- and chemotherapy used during cancer treatment.
Arnold's project is titled "Forward genetic analysis of mammalian resistance and susceptibility to viral infection." Garaigorta's is titled "Regulation of Hepatitis C Virus Infection by Interferon-Inducible Micro-RNAs."
Send comments to: mikaono[at]scripps.edu
|
Green Car |
||||||